<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="428">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 01, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01357707</url>
  </required_header>
  <id_info>
    <org_study_id>EA1_215_08</org_study_id>
    <secondary_id>SFB 665 TP C4</secondary_id>
    <nct_id>NCT01357707</nct_id>
  </id_info>
  <brief_title>Clinical-genetic Investigations in Children With Early Infantile Epilepsies</brief_title>
  <official_title>Clinical-genetic Investigations in Children With Early Infantile Epilepsies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Markus Schuelke, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mainz University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Kiel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <authority>Germany: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project strives to discover novel genetic defects that cause monogenic epilepsy or that
      genetically modify a preexisting epileptic phenotype. Our main aim is to find genetic causes
      for the idiopathic West Syndrome (infantile seizures) that are not caused by known cerebral
      malformation, lissencephaly or metabolic disorders and which have a comparatively benign
      prognosis.

      The investigators hypothesize that mutations in genes coding for ion channels or genes that
      modify the action of ion channels might be causative.

      For that the investigators will perform a sequence analysis of the coding exons of a large
      set of genes in all recruited patients and verify found mutations in their parents.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Family-Based, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Discovery of a pathogenic mutation in an ion channel gene</measure>
    <time_frame>4 weeks after taking of the DNA specimen</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Epilepsy</condition>
  <condition>Seizures, Infantile</condition>
  <arm_group>
    <arm_group_label>West Syndrome (idiopathic)</arm_group_label>
    <description>Patients with idiopathic infantile seizures</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>DNA preparation</intervention_name>
    <description>Taking blood or saliva from the patient to prepare DNA therefrom</description>
    <arm_group_label>West Syndrome (idiopathic)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA isolated from blood cells or from saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with infantile seizures without brain malformations, metabolic disorders of
        lissencephaly who had a good outcome and are seizure free (with or without AEDs) after the
        age of 5 years.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypsarrhythmia in the first year of life

          -  Infantile seizures in the first year of life

          -  Freedom of seizures at the age of 5 years

        Exclusion Criteria:

          -  brain malformation

          -  metabolic disorder

          -  intracranial hemorrhage

          -  lissencephaly
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Charité Universitätsmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Schuelke, M.D.</last_name>
      <phone>+49 30 4505 66468</phone>
      <email>markus.schuelke@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Ellen Knierim, M.D.</last_name>
      <phone>+49 30 450 539015</phone>
      <email>ellen.knierim@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Markus Schuelke, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ellen Knierim, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 5, 2013</lastchanged_date>
  <firstreceived_date>May 19, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Markus Schuelke, M.D.</investigator_full_name>
    <investigator_title>Prinicpal investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
